These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4016278)

  • 1. Evaluation of covalent antisickling compounds by PO2 scan ektacytometry.
    Johnson RM; Féo CJ; Nossal M; Dobo I
    Blood; 1985 Aug; 66(2):432-8. PubMed ID: 4016278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bepridil as an antisickling agent: membrane internalization and cell rigidity.
    Johnson RM; Acquaye C; Féo C; Sarnaik S
    Am J Hematol; 1994 Aug; 46(4):310-8. PubMed ID: 8037182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
    Kuranstin-Mills J; Lessin LS
    Blood Cells; 1982; 8(2):315-28. PubMed ID: 7159755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of fifteen anti-sickling agents.
    Chang H; Ewert SM; Bookchin RM; Nagel RL
    Blood; 1983 Apr; 61(4):693-704. PubMed ID: 6338971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of 3 varieties of antisickling substances measured by ektacytometry as a function of oxygen pressure].
    Feo CJ; Johnson RM; Nossal M
    C R Seances Acad Sci III; 1983; 296(19):911-6. PubMed ID: 6412992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of red cell deformability during progressive deoxygenation and oxygenation in sickling disorders (the use of an automated Ektacytometer).
    Bessis M; Feo C; Jones E
    Blood Cells; 1982; 8(1):17-28. PubMed ID: 7115975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand kinetics of hemoglobin S containing erythrocytes.
    Harrington JP; Elbaum D; Bookchin RM; Wittenberg JB; Nagel RL
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):203-6. PubMed ID: 264675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
    Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
    Sablayrolles M; Wajcman H; Castaigne JP; Labie D
    Am J Hematol; 1985 Feb; 18(2):121-30. PubMed ID: 3970009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
    Berkowitz LR; Orringer EP
    J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanillin, a potential agent for the treatment of sickle cell anemia.
    Abraham DJ; Mehanna AS; Wireko FC; Whitney J; Thomas RP; Orringer EP
    Blood; 1991 Mar; 77(6):1334-41. PubMed ID: 2001455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisickling activity of amino acid benzyl esters.
    Gorecki M; Acquaye CT; Wilchek M; Votano JR; Rich A
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):181-5. PubMed ID: 6928612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding antisickling agents and the sickling process.
    Godwin M; Baysinger M
    Nurs Clin North Am; 1983 Mar; 18(1):207-14. PubMed ID: 6550864
    [No Abstract]   [Full Text] [Related]  

  • 19. Deformability of isolated red blood cell membranes.
    Heath BP; Mohandas N; Wyatt JL; Shohet SB
    Biochim Biophys Acta; 1982 Oct; 691(2):211-9. PubMed ID: 6814487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.